RedHill Biopharma Ltd http://www.redhillbio.com Wed, 15 Feb 2012 11:34:14 +0000 en hourly 1 http://wordpress.org/?v=3.1.3 RedHill Biopharma’s RHB-102 (prevention of nausea and vomiting) advanced clinical trial has began http://www.redhillbio.com/news/redhill-biopharmas-rhb-102-prevention-of-nausea-and-vomiting-advanced-clinical-trial-has-began/ http://www.redhillbio.com/news/redhill-biopharmas-rhb-102-prevention-of-nausea-and-vomiting-advanced-clinical-trial-has-began/#comments Wed, 15 Feb 2012 11:34:14 +0000 AdiFrish http://www.redhillbio.com/?p=937 RedHill Biopharma commences advanced clinical trial with RHB-102 (Nausea and Vomiting) (February 14 2012)

RedHill Biopharma commenced advanced clincial trial with RHB-102 (Nausea and Vomiting) (February 14 2012) Hebrew

]]> http://www.redhillbio.com/news/redhill-biopharmas-rhb-102-prevention-of-nausea-and-vomiting-advanced-clinical-trial-has-began/feed/ 0 RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (Prevention of Nausea and Vomiting) http://www.redhillbio.com/news/redhill-biopharma-obtains-fda-ind-for-advanced-clinical-trial-with-rhb-102-prevention-of-nausea-and-vomiting/ http://www.redhillbio.com/news/redhill-biopharma-obtains-fda-ind-for-advanced-clinical-trial-with-rhb-102-prevention-of-nausea-and-vomiting/#comments Mon, 13 Feb 2012 08:59:50 +0000 AdiFrish http://www.redhillbio.com/?p=927 RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (Nausea and Vomiting) Feb 12th 2012

RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (Nausea and Vomiting) Feb 12th 2012 (Hebrew)

]]> http://www.redhillbio.com/news/redhill-biopharma-obtains-fda-ind-for-advanced-clinical-trial-with-rhb-102-prevention-of-nausea-and-vomiting/feed/ 0 RedHill Biopharma obtains a CTA approval from Health Canada to commence an advanced trial with RHB-102 (prevention of nausea & vomiting) http://www.redhillbio.com/news/redhill-biopharma-obtains-a-cta-approval-from-health-canada-to-commence-an-advanced-trial-with-rhb-102-nausea-vomiting/ http://www.redhillbio.com/news/redhill-biopharma-obtains-a-cta-approval-from-health-canada-to-commence-an-advanced-trial-with-rhb-102-nausea-vomiting/#comments Tue, 07 Feb 2012 14:56:54 +0000 AdiFrish http://www.redhillbio.com/?p=916 RedHill Biopharma obtains a CTA approval to commence an advanced trial with RHB-102 (prevention of nausea & vomiting) (February 5th 2012)

RedHill Biopharma obtains a CTA approval to commence an advanced trial with RHB-102 (prevention of nausea & vomiting) (February 5th 2012) Hebrew

]]> http://www.redhillbio.com/news/redhill-biopharma-obtains-a-cta-approval-from-health-canada-to-commence-an-advanced-trial-with-rhb-102-nausea-vomiting/feed/ 0 Mr. Gilead Raday’s interview on Israel21c, regarding RHB-102 (prevention of nausea & vomiting in cancer patients) http://www.redhillbio.com/news/mr-gilead-radays-interview-on-israel21c-regarding-rhb-102-prevention-of-nausea-vomiting-in-cancer-patient/ http://www.redhillbio.com/news/mr-gilead-radays-interview-on-israel21c-regarding-rhb-102-prevention-of-nausea-vomiting-in-cancer-patient/#comments Thu, 02 Feb 2012 12:54:27 +0000 AdiFrish http://www.redhillbio.com/?p=913 See Mr. Gilead Raday’s interview on Israel21c, regarding RHB-102 (prevention of nausea & vomiting in cancer patients):

http://israel21c.org/health/daily-pill-to-vanquish-nausea-after-chemo

]]> http://www.redhillbio.com/news/mr-gilead-radays-interview-on-israel21c-regarding-rhb-102-prevention-of-nausea-vomiting-in-cancer-patient/feed/ 0 IntelGenx, RedHill’s Development Partner in RHB-103 (Migraine) Announces Health Canada Approval for Pivotal Trial http://www.redhillbio.com/news/intelgenx-redhills-development-partner-in-rhb-103-migraine-announce-health-canada-approval-for-pivotal-trial-2/ http://www.redhillbio.com/news/intelgenx-redhills-development-partner-in-rhb-103-migraine-announce-health-canada-approval-for-pivotal-trial-2/#comments Mon, 02 Jan 2012 08:55:09 +0000 AdiFrish http://www.redhillbio.com/?p=904 IntelGenx, RedHill’s Development Partner in RHB-103 (Migraine) Announces Health Canada Approval for Pivotal Trial

]]> http://www.redhillbio.com/news/intelgenx-redhills-development-partner-in-rhb-103-migraine-announce-health-canada-approval-for-pivotal-trial-2/feed/ 0 Dr. Jeff Lehighton presents RedHill Biopharma on Bloomberg TV http://www.redhillbio.com/news/dr-jeff-lehighton-presents-redhill-biopharma-on-bloomberg-tv/ http://www.redhillbio.com/news/dr-jeff-lehighton-presents-redhill-biopharma-on-bloomberg-tv/#comments Wed, 23 Nov 2011 11:46:37 +0000 AdiFrish http://www.redhillbio.com/?p=878 Please use the link below to watch Dr. Jeff Lehighton, RedHill Biopharma’s Chairman of the Advisory Board, on Bloomberg TV:

http://www.bloomberg.com/video/80653140/

]]> http://www.redhillbio.com/news/dr-jeff-lehighton-presents-redhill-biopharma-on-bloomberg-tv/feed/ 0 RedHill Biopharma engages with CRO for potential pivotal trial with RHB-102 (prevention of nausea & vomiting in cancer patients) http://www.redhillbio.com/news/redhill-biopharma-engages-with-cro-for-potential-pivotal-trial-with-rhb-102-prevention-of-nausea-vomiting-in-cancer-patients/ http://www.redhillbio.com/news/redhill-biopharma-engages-with-cro-for-potential-pivotal-trial-with-rhb-102-prevention-of-nausea-vomiting-in-cancer-patients/#comments Fri, 04 Nov 2011 16:07:44 +0000 AdiFrish http://www.redhillbio.com/?p=865 RedHill engages with CRO for potential pivotal trial with RHB-102 (Prevention of Nausea Vomiting ) (Hebrew)

RedHill engages with CRO in preparation for potential pivotal trial with RHB-102 (prevention of nausea & vomiting )

]]> http://www.redhillbio.com/news/redhill-biopharma-engages-with-cro-for-potential-pivotal-trial-with-rhb-102-prevention-of-nausea-vomiting-in-cancer-patients/feed/ 0 RedHill Biopharma appoints Prof. Colm O’Morain, MD as Lead Investigator for the European Phase III trial with RHB-104 (Crohn’s) http://www.redhillbio.com/news/redhill-biopharma-appoints-prof-colm-omorain-md-as-lead-investigator-for-the-european-pivotal-trial-with-rhb-104-crohn%e2%80%99s/ http://www.redhillbio.com/news/redhill-biopharma-appoints-prof-colm-omorain-md-as-lead-investigator-for-the-european-pivotal-trial-with-rhb-104-crohn%e2%80%99s/#comments Tue, 25 Oct 2011 12:18:48 +0000 AdiFrish http://www.redhillbio.com/?p=854 RedHill appoints Prof O’Morain as Lead Investigator for the European Phase III clinical trial with RHB-104 (Crohn’s) Hebrew

Redhill appoints Prof O’Morain as Lead Investigator for the European Phase III trial with RHB-104 – Crohn’s (October 24 2011)

]]> http://www.redhillbio.com/news/redhill-biopharma-appoints-prof-colm-omorain-md-as-lead-investigator-for-the-european-pivotal-trial-with-rhb-104-crohn%e2%80%99s/feed/ 0 RedHill Biopharma appoints Prof. David Y. Graham, MD as Lead Investigator for the US pivotal trial with RHB-104 (Crohn’s) http://www.redhillbio.com/news/redhill-biopharma-appoints-prof-david-y-graham-md-as-lead-investigator-for-the-us-pivotal-trial-with-rhb-104-crohns/ http://www.redhillbio.com/news/redhill-biopharma-appoints-prof-david-y-graham-md-as-lead-investigator-for-the-us-pivotal-trial-with-rhb-104-crohns/#comments Thu, 06 Oct 2011 10:37:33 +0000 AdiFrish http://www.redhillbio.com/?p=839 RedHill Biopharma appoints Prof Graham as Lead Investigator for RHB-104 – Crohn’s (Hebrew) (October 5, 2011)

RedHill Biopharma appoints Prof Graham as Lead Investigator for the US pivotal trial with RHB-104 – Crohn’s (October 5, 2011)

]]> http://www.redhillbio.com/news/redhill-biopharma-appoints-prof-david-y-graham-md-as-lead-investigator-for-the-us-pivotal-trial-with-rhb-104-crohns/feed/ 0 RedHill Biopharma Acquires Exclusive Rights to a MAP Bacterium Companion Diagnostic Test for its RHB-104 (Crohn’s) http://www.redhillbio.com/news/redhill-biopharma-acquires-exclusive-rights-to-a-map-bacterium-companion-diagnostic-test-for-its-rhb-104-crohn%e2%80%99s-drug/ http://www.redhillbio.com/news/redhill-biopharma-acquires-exclusive-rights-to-a-map-bacterium-companion-diagnostic-test-for-its-rhb-104-crohn%e2%80%99s-drug/#comments Mon, 26 Sep 2011 08:50:58 +0000 AdiFrish http://www.redhillbio.com/?p=833 RedHill acquires exclusive rights to a diagnostic test for RHB-104 – Crohn’s (Sep. 19 2011)

]]> http://www.redhillbio.com/news/redhill-biopharma-acquires-exclusive-rights-to-a-map-bacterium-companion-diagnostic-test-for-its-rhb-104-crohn%e2%80%99s-drug/feed/ 0